Vorolanib (Synonyms: CM082; X-82) |
Katalog-Nr.GC38380 |
Vorolanib (CM082) ist ein oral aktiver, potenter Multikinase-VEGFR/PDGFR-Hemmer.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1013920-15-4
Sample solution is provided at 25 µL, 10mM.
Vorolanib (CM082; X-82) is an orally active, multikinase VEGFR/PDGFR inhibitor. Vorolanib minimizes toxicity, disrupts tumor angiogenesis and tumor cell proliferation, and induces of tumor cell death[1].
[1]. Bendell JC, et al. Phase I, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors. Oncologist. 2019 Apr;24(4):455-e121.
Average Rating: 5
(Based on Reviews and 36 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *